Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.

Gupta, RKORCID logo; Calderwood, CJORCID logo; Yavlinsky, A; Krutikov, MORCID logo; Quartagno, M; Aichelburg, MC; Altet, N; Diel, R; Dobler, CCORCID logo; Dominguez, J; +27 more...Doyle, JS; Erkens, C; Geis, S; Haldar, PORCID logo; Hauri, AMORCID logo; Hermansen, T; Johnston, JC; Lange, C; Lange, B; van Leth, FORCID logo; Muñoz, L; Roder, C; Romanowski, K; Roth, D; Sester, MORCID logo; Sloot, R; Sotgiu, GORCID logo; Woltmann, GORCID logo; Yoshiyama, T; Zellweger, J; Zenner, D; Aldridge, RW; Copas, A; Rangaka, MX; Lipman, M; Noursadeghi, MORCID logo; Abubakar, IORCID logo and (2020) Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nature medicine, 26 (12). pp. 1941-1949. ISSN 1078-8956 DOI: 10.1038/s41591-020-1076-0
Copy

The risk of tuberculosis (TB) is variable among individuals with latent Mycobacterium tuberculosis infection (LTBI), but validated estimates of personalized risk are lacking. In pooled data from 18 systematically identified cohort studies from 20 countries, including 80,468 individuals tested for LTBI, 5-year cumulative incident TB risk among people with untreated LTBI was 15.6% (95% confidence interval (CI), 8.0-29.2%) among child contacts, 4.8% (95% CI, 3.0-7.7%) among adult contacts, 5.0% (95% CI, 1.6-14.5%) among migrants and 4.8% (95% CI, 1.5-14.3%) among immunocompromised groups. We confirmed highly variable estimates within risk groups, necessitating an individualized approach to risk stratification. Therefore, we developed a personalized risk predictor for incident TB (PERISKOPE-TB) that combines a quantitative measure of T cell sensitization and clinical covariates. Internal-external cross-validation of the model demonstrated a random effects meta-analysis C-statistic of 0.88 (95% CI, 0.82-0.93) for incident TB. In decision curve analysis, the model demonstrated clinical utility for targeting preventative treatment, compared to treating all, or no, people with LTBI. We challenge the current crude approach to TB risk estimation among people with LTBI in favor of our evidence-based and patient-centered method, in settings aiming for pre-elimination worldwide.


picture_as_pdf
Gupta-etal-2020-Discovery-and-validation-of-a-personalized-risk-predictor-for-incident-tuberculosis-in-low-transmission-settings.pdf
subject
Accepted Version
error
This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
copyright
Available under Copyright the publishers

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads